middle.news
Bioxyne Surges 77% in Q2 Revenue, Eyes UK and European Expansion
7:03pm on Monday 2nd of June, 2025 AEST
•
Pharmaceuticals
Read Story
Bioxyne Surges 77% in Q2 Revenue, Eyes UK and European Expansion
7:03pm on Monday 2nd of June, 2025 AEST
Key Points
Q2 revenue of $6.1 million, up 77% from Q1 and 310% year-on-year
Positive operating cash flow of $1.5 million for the quarter
Manufacturing capacity expansion to triple pastilles output by February 2025
Regulatory approvals imminent for UK exports of Dr Watson products
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
BXN
OPEN ARTICLE